|
gptkbp:instanceOf
|
gptkb:drug
bronchodilator
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
1968
|
|
gptkbp:ATCCode
|
R03AC02
|
|
gptkbp:brand
|
gptkb:Proventil
gptkb:Ventolin
ProAir
|
|
gptkbp:CASNumber
|
18559-94-9
|
|
gptkbp:category
|
gptkb:essential_medicine_(WHO)
|
|
gptkbp:color
|
white (powder)
|
|
gptkbp:contraindication
|
hypersensitivity to albuterol
|
|
gptkbp:developedBy
|
gptkb:Allen_&_Hanburys
|
|
gptkbp:drugClass
|
short-acting beta-2 agonist
|
|
gptkbp:eliminationHalfLife
|
3.8-6 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:sugar
gptkb:tablet
inhaler
nebulizer solution
|
|
gptkbp:hasMolecularFormula
|
C13H21NO3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
albuterol
|
|
gptkbp:interactsWith
|
gptkb:tricyclic_antidepressants
gptkb:monoamine_oxidase_inhibitors
gptkb:digoxin
beta blockers
diuretics
|
|
gptkbp:IUPACName
|
4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
beta-2 adrenergic agonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
239.31 g/mol
|
|
gptkbp:otherName
|
gptkb:salbutamol
|
|
gptkbp:overdoseSymptoms
|
chest pain
seizures
hypokalemia
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
|
|
gptkbp:sideEffect
|
headache
tremor
nervousness
tachycardia
palpitations
muscle cramps
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
asthma
chronic obstructive pulmonary disease
|
|
gptkbp:bfsParent
|
gptkb:Clenbuterol
gptkb:ADRB2_gene
gptkb:beta-2_adrenergic_receptor
|
|
gptkbp:bfsLayer
|
7
|